Professor Lencioni ILCA 2011.pdf - Biocompatibles
Professor Lencioni ILCA 2011.pdf - Biocompatibles
Professor Lencioni ILCA 2011.pdf - Biocompatibles
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Conventional TACE: treatment discontinuationdue to AEs or technical issues is common• Reasons for treatment discontinuation among HCC patients who received aconventional TACE regimen with doxorubin, Lipiodol, and gelatine spongefragmentsadapted from Llovet JM et al. Lancet 2002;359:1734–9